We investigated polymorphisms of plasminogen activator inhibitor-1 (PAI-1), angiotensin converting enzyme (ACE ) and coagulation factor XIII (FXIII) genes and their association with recurrent spontaneous abortion (RSA) in Iranian patients and normal healthy controls. Ten (18.5%) patients were homozygote (4G/4G) for PAI-1 polymorphism, in contrast with two (2%) controls (p = 0.001). Patients with homozygote 4G mutation were significantly more prone to RSA in contrast to others (odds ratio: 11.0, 95% CI: 2.3-52.4). Nineteen (30.2%) patients and 25 (26.6%) controls were homozygote (DD) for ACE polymorphism. We observed only two patients and one control with homozygosity (34leu) for FXIII polymorphism. 4G/4G polymorphism for PAI-1 gene could be...
Abstract Background: The pathogenesis of recurrent pregnancy loss includes complex interaction of s...
Background: Plasminogen activator inhibitor type 1 (PAI-1) is an important regulator of fibrinolysis...
Objective: To investigate the potential association of tissue inhibitor of metalloproteinases (TIMP)...
Background: Spontaneous abortion is considered as the most complex problem during pregnancy. Thrombo...
Recurrent pregnancy loss (RPL) is a significant clinical problem that may occur before the 20th ...
BACKGROUND: Successful pregnancies require ®ne tuning of ®brinolytic activities in order to secure ®...
Abstract The insertion/deletion (I/D) polymorphism in intron 16 of the angiotensin I-converting enz...
Problem: Among important suspected causes of thrombophilia in women with recurrent pregnancy loss (R...
Introduction: One factor known to cause thrombophilia in women with unexplained recurrent spontaneou...
of plasminogen activator inhibitor-1 and angiotensin converting enzyme polymorphisms with recurrent ...
Impaired fibrinolytic activity is implicated in the pathogenesis of recurrent spontaneous abortion (...
Introduction: Among the genetic factors for coronary artery diseases, PAI-1 4G/5G and ACE I/D polymo...
Background and Objective: The mutation of F2 and PAI-1 genes can cause thrombophilia in women. The p...
Background: Recurrent spontaneous abortion (RSA) has traditionally been defined by two or more conse...
The balance between coagulation and fibrinolysis is essential for a successful pregnancy. This study...
Abstract Background: The pathogenesis of recurrent pregnancy loss includes complex interaction of s...
Background: Plasminogen activator inhibitor type 1 (PAI-1) is an important regulator of fibrinolysis...
Objective: To investigate the potential association of tissue inhibitor of metalloproteinases (TIMP)...
Background: Spontaneous abortion is considered as the most complex problem during pregnancy. Thrombo...
Recurrent pregnancy loss (RPL) is a significant clinical problem that may occur before the 20th ...
BACKGROUND: Successful pregnancies require ®ne tuning of ®brinolytic activities in order to secure ®...
Abstract The insertion/deletion (I/D) polymorphism in intron 16 of the angiotensin I-converting enz...
Problem: Among important suspected causes of thrombophilia in women with recurrent pregnancy loss (R...
Introduction: One factor known to cause thrombophilia in women with unexplained recurrent spontaneou...
of plasminogen activator inhibitor-1 and angiotensin converting enzyme polymorphisms with recurrent ...
Impaired fibrinolytic activity is implicated in the pathogenesis of recurrent spontaneous abortion (...
Introduction: Among the genetic factors for coronary artery diseases, PAI-1 4G/5G and ACE I/D polymo...
Background and Objective: The mutation of F2 and PAI-1 genes can cause thrombophilia in women. The p...
Background: Recurrent spontaneous abortion (RSA) has traditionally been defined by two or more conse...
The balance between coagulation and fibrinolysis is essential for a successful pregnancy. This study...
Abstract Background: The pathogenesis of recurrent pregnancy loss includes complex interaction of s...
Background: Plasminogen activator inhibitor type 1 (PAI-1) is an important regulator of fibrinolysis...
Objective: To investigate the potential association of tissue inhibitor of metalloproteinases (TIMP)...